The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Advances in colon-targeted nano-drug delivery systems: challenges and solutions
Abstract
Nano-drug delivery systems (NDDS) for colon-targeted drug delivery are an active area of research on local diseases affecting the colon, such as ulcerative colitis, Crohn's disease, colon cancer, and for the delivery of peptide or protein drugs and vaccinations. In particular, targeted nano-drug delivery to the colon is advantageous for colon-specific diseases because nanoparticles can accumulate in diseased parts, improve the efficacies of therapeutics, and enable localized treatments, which reduces systemic toxicity. However, there are many hurdles, such as burst drug release, enzyme and acidic degradation of drug and carrier in the stomach, pH variations, mucus entrapment, and systemic uptake in the upper small intestine, which could challenge and compromise the successful delivery of NDDS to the colon. With advancements in NDDS, it may be possible to overcome these challenges leading to efficient drug delivery for colon-specific disorders. This review describes a few of the potential colon-specific drug delivery areas and the challenges faced by colon-targeted orally administered delivery systems, and provides an updated summary of recent advances in the development of orally administered NDDS for colon targeting, and the future advances in this research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Colonic drug delivery is beneficial for treating arthritis, angina, nocturnal asthma, and colonic disorders such as colorectal cancer, Crohn’s disease, and ulcerative colitis (Arévalo-Pérez et al., 2020; Lee et al., 2020; Naeem et al., 2020; Cui et al., 2021).”
From pH stimuli-responsive hydrogels from non-cellulosic biopolymers for drug delivery. (2023) · cites this paper as Naeem et al., 2020
Citations
Cites
Colorectal cancer statistics, 2014
Siegel, R. L., Desantis, C. E., & Jemal, A. (2014) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21220 · Cited by 2,598
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,863
Cone, R. A. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459
Cunningham, D., Atkin, W. S., Lenz, H., Lynch, H. T., Minsky, B. D., Nordlinger, B., & Starling, N. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60353-4 · Cited by 1,447
Pelaseyed, T., Bergström, J. H., Gustafsson, J. K., Ermund, A., Birchenough, G. M. H., Schütte, A., van der Post, S., Svensson, F., Rodríguez‐Piñeiro, A. M., Nyström, E. E. L., et al. (2014) · Immunological Reviews · doi:10.1111/imr.12182 · Cited by 1,363
Intestinal Inflammation and Cancer
Ullman, T. A., & Itzkowitz, S. H. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.057 · Cited by 1,127
Zhang, M., Viennois, É., Prasad, M. A., Zhang, Y., Wang, L., Zhang, Z., Han, M. K., Xiao, B., Xu, C., Srinivasan, S., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.018 · Cited by 1,071
Duchmann, R., Kaiser, I., Hermann, E., Mayet, W.-J., Ewe, K., & BÜSCHENFELDE, K.-H. M. Z. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03836.x · Cited by 938
Ju, S., Mu, J., Dokland, T., Zhuang, X., Wang, Q., Jiang, H., Xiang, X., Deng, Z., Wang, B., Zhang, L., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.64 · Cited by 889
Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
Tsilidis, K. K., Kasimis, J. C., López, D. S., Ntzani, E., & Ioannidis, J. P. A. (2015) · BMJ · doi:10.1136/bmj.g7607 · Cited by 885
Cited by
Sorted by citations
Smart drug delivery systems for precise cancer therapy
Wang, X., Li, C., Wang, Y., Chen, H., Zhang, X., Luo, C., Zhou, W., Li, L., Teng, L., Yu, H., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.08.013 · Cited by 256
Li, S., Zhang, H., Chen, K., Jin, M., Vu, S. H., Jung, S., He, N., Zhou, Z. G., & Lee, M. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2058646 · Cited by 221
Mucoadhesive carriers for oral drug delivery
Kumar, R., Islam, T., & Nurunnabi, M. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.024 · Cited by 212
dos Santos, A. M., Carvalho, S. G., Meneguin, A. B., Sábio, R. M., Gremião, M. P. D., & Chorilli, M. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.04.026 · Cited by 178
Current-status and applications of polysaccharides in drug delivery systems
Prasher, P., Sharma, M., Mehta, M., Satija, S., Aljabali, A. A. A., Tambuwala, M. M., Anand, K., Sharma, N., Dureja, H., Jha, N. K., et al. (2021) · Colloids and Interface Science Communications · doi:10.1016/j.colcom.2021.100418 · Cited by 175
Metadata
- Authors
- Naeem, M., Awan, U. A., Subhan, F., Cao, J., Hlaing, S. P., Lee, J., Im, E., Jung, Y., & Yoo, J.-W.
- Affiliations
- National University of Medical Sciences (PK)
- Pusan National University (KR)
- Corresponding author
- Yoo, Jin-Wook
- ORCID
- Venue
- Archives of Pharmacal Research
- Published
- 2020-01
- Volume
- 43
- Issue
- 1
- Pages
- 153-169
- ISSN
- 0253-6269 (ISSN-L)
- 1976-3786
- OpenAlex
- W3000884526
- Cited by
- 248
- References
- 138
- Citations by year
- 2026: 22 · 2025: 57 · 2024: 44 · 2023: 50 · 2022: 40 · 2021: 20 · 2020: 14
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Pharmacal Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education (NRF-2019R1I1A3A01057849)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Keywords
- colon-targeted drug delivery, nanoparticle drug delivery, oral drug delivery, gastrointestinal pH, enzyme degradation, ulcerative colitis, Crohn's disease, colon cancer
- MeSH terms
- Animals, Colonic Diseases, Drug Carriers, Humans, Hydrogen-Ion Concentration, Drug Delivery Systems, Nanoparticles, Drug Liberation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
